Literature DB >> 24526252

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?

Gareth Lewis1, Alexander P Maxwell.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24526252     DOI： 10.1007/s00125-014-3188-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy.

Authors:  J Bar; R Chen; A Schoenfeld; R Orvieto; J Yahav; Z Ben-Rafael; M Hod
Journal:  J Pediatr Endocrinol Metab       Date:  1999 Sep-Oct       Impact factor: 1.634

Review 2.  Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.

Authors:  Janine E Polifka
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-07-17

3.  Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Authors:  M Porta; J W Hainer; S-O Jansson; A Malm; R Bilous; N Chaturvedi; J H Fuller; R Klein; T Orchard; H-H Parving; A-K Sjølie
Journal:  Diabetologia       Date:  2011-01-12       Impact factor: 10.122

4.  Major congenital malformations after first-trimester exposure to ACE inhibitors.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon Dyer; Patricia S Gideon; Kathi Hall; Wayne A Ray
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 5.  Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review.

Authors:  Marina Bullo; Sibylle Tschumi; Barbara S Bucher; Mario G Bianchetti; Giacomo D Simonetti
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

6.  Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?

Authors:  Lene Ringholm Nielsen; Peter Damm; Elisabeth R Mathiesen
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 19.112

Review 7.  Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment.

Authors:  Elisabeth R Mathiesen; Lene Ringholm; Bo Feldt-Rasmussen; Peter Clausen; Peter Damm
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

8.  Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study.

Authors:  Peter W G Tennant; Svetlana V Glinianaia; Rudy W Bilous; Judith Rankin; Ruth Bell
Journal:  Diabetologia       Date:  2013-11-29       Impact factor: 10.122
  8 in total
  6 in total

1.  Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter].

Authors:  Peter W G Tennant; Svetlana V Glinianaia; Rudy W Bilous; Judith Rankin; Ruth Bell
Journal:  Diabetologia       Date:  2014-02-15       Impact factor: 10.122

2.  Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study.

Authors:  Maria Hoeltzenbein; Tatjana Tissen-Diabaté; Anne-Katrin Fietz; Sandra Zinke; Angela Kayser; Reinhard Meister; Corinna Weber-Schoendorfer; Christof Schaefer
Journal:  Clin Res Cardiol       Date:  2018-03-24       Impact factor: 5.460

Review 3.  A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.

Authors:  Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2016-03-17       Impact factor: 3.902

4.  Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study.

Authors:  Jie-Ming Nie; Hai-Feng Li
Journal:  Exp Ther Med       Date:  2018-08-24       Impact factor: 2.447

Review 5.  A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology.

Authors:  Gianfranca Cabiddu; Donatella Spotti; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Gina Gregorini; Franca Giacchino; Rossella Attini; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2018-06-14       Impact factor: 3.902

Review 6.  Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis.

Authors:  Rossella Siligato; Guido Gembillo; Valeria Cernaro; Francesco Torre; Antonino Salvo; Roberta Granese; Domenico Santoro
Journal:  Front Med (Lausanne)       Date:  2020-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.